Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Recent Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Antibiotics and Affect: Avenues for Addiction Management
Addictions to cocaine and other stimulant 'designer' drugs remain unaided by pharmacotherapies. Several...
Open Insulin
A team of biohackers is developing the first open source protocol to produce insulin simply and economically...
Synthesis of a Kidney Cancer Drug
We need to prepare a 75 mg sample of our anti-kidney cancer drug for testing. The sample was requested by...